Actively Recruiting
Patient Reported Outcomes/Metrics Program Trial
Led by University Health Network, Toronto · Updated on 2026-03-05
100
Participants Needed
1
Research Sites
248 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational study to investigate if it is feasible to recruit 100 patients receiving radiotherapy (RT) to metastatic disease to wear Hexoskin and if Hexoskin will facilitate the monitoring, detection and early treatment of RT-related side effects.
CONDITIONS
Official Title
Patient Reported Outcomes/Metrics Program Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Planned to receive palliative radiotherapy for pain
- Known cancer diagnosis
- Able to wear Hexoskin Medical Shirt
- Ability to use and populate the mobile app (Zamplo) with or without assistance
- ECOG performance status of 0 to 3
- Willing to provide a list of analgesic (pain relief) medications
- Willing to complete questionnaires
- Life expectancy of at least 3 months
You will not qualify if you...
- Receiving whole brain radiotherapy
- Major cognitive or psychiatric impairments
- Pregnant women
- Allergies to polyester or synthetic fibers
- Patients with pacemakers or implantable cardioverter-defibrillators (ICD)
- Patients using a Holter Monitor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9
Actively Recruiting
Research Team
P
Philip Wong
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here